Health Care & Life Sciences » Pharmaceuticals | Coral Laboratories Ltd.

Coral Laboratories Ltd. | Cash Flow

Fiscal year is April-March. All values INR Thousands.
2014
2015
2016
2017
2018
Net Income before Extraordinaries
99,306.50
122,099.40
174,015.20
248,859.00
-
Depreciation, Depletion & Amortization
12,385.40
25,668.10
17,305.30
15,569.50
-
Other Funds
27,497.40
33,098.00
54,200.60
89,410.70
-
Funds from Operations
84,194.40
114,669.60
137,119.80
175,017.80
140,066.00
Changes in Working Capital
63,688.20
98,329.40
60,510.00
28,546.10
-
Net Operating Cash Flow
20,506.20
16,340.20
76,609.80
146,471.70
-
Capital Expenditures
1,994.30
17,487.10
9,179.60
22,908.40
-
Sale of Fixed Assets & Businesses
-
-
236.90
3,350.00
-
Purchase/Sale of Investments
-
-
34,092.00
92,751.20
-
Net Investing Cash Flow
1,994.30
17,487.10
43,034.80
112,309.60
-
Cash Dividends Paid - Total
-
-
10,749.70
-
-
Issuance/Reduction of Debt, Net
-
-
-
5.50
-
Net Financing Cash Flow
-
-
10,749.70
5.50
-
Net Change in Cash
18,511.90
1,146.90
22,825.30
34,156.50
-
Free Cash Flow
18,511.90
1,072.60
67,745.10
123,563.30
-
Other Sources
-
-
-
0.00
-

About Coral Laboratories

View Profile
Address
3-B, Patanwala Compound
Mumbai Maharashtra 400086
India
Employees -
Website http://www.corallab.com
Updated 09/14/2018
Coral Laboratories Ltd. engages in the manufacture of pharmaceutical formulations. It operates through the following geographical segments: Ethopia, India, and Rest of World. Its products include tablets, capsules, liquids, topical preparations, eye and ear drops, and injectables.